MIRA Pharmaceuticals Inc. (MIRA)
NASDAQ: MIRA
· Real-Time Price · USD
1.31
0.01 (0.77%)
At close: Sep 26, 2025, 10:57 AM
0.77% (1D)
| Bid | 1.31 |
| Market Cap | 25.06M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -7.77M |
| EPS (ttm) | -0.47 |
| PE Ratio (ttm) | -2.8 |
| Forward PE | -13.5 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.33 |
| Volume | 41,968 |
| Avg. Volume (20D) | 1,528,223 |
| Open | 1.32 |
| Previous Close | 1.30 |
| Day's Range | 1.30 - 1.32 |
| 52-Week Range | 0.73 - 2.56 |
| Beta | 1.77 |
| Ex-Dividend Date | n/a |
About MIRA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MIRA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MIRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
-4.83%
MIRA stock has given up its prior gain. MIRA Pharm...
Unlock content with
Pro Subscription
1 week ago
-4.83%
MIRA Pharmaceuticals shares are trading higher after the company announced results from a proof-of-concept validation study evaluating Ketamir-2 in an animal model of post-traumatic stress disorder
